CNBX Pharmaceuticals
$0.000200
26
+$0.00+29.03% Monday 18:40
Statistics
Day High
0.0002
Day Low
0.0001
52W High
0.0014
52W Low
0.0001
Volume
-
Avg. Volume
-
Mkt Cap
174,153.6
P/E Ratio
0
Dividend Yield
-
Dividend
-
Earnings
12AprExpected
Expected EPS
N/A
Actual EPS
-0.01
Financials
-Profit Margin
Unprofitable0Revenue
-628,000Net Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow CNBX. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Corbus Pharmaceuticals
CRBP
Mkt Cap140.07M
Tilray Brands
TLRY
Mkt Cap590.84M
Canopy Growth
CGC
Mkt Cap462.55M
Aurora Cannabis
ACB
Mkt Cap199.85M
About
CNBX Pharmaceuticals Inc. is a biopharmaceutical firm dedicated to discovering, developing, and commercializing cannabinoid-based treatments and therapies for various cancers. Its flagship product candidate, RCC-33, is an oral capsule formulation of cannabinoids specifically engineered for treating colorectal cancer. The company's development pipeline also encompasses several other potential drug candidates, including PLP-33, which targets lateral spreading or sessile colorectal polyps during colonoscopy; BRST-33, aimed at breast cancer; MLN-33, designed for melanoma; and PRST-33, intended for prostate cancer. Furthermore, CNBX is developing Cannabics SR, a lipid-based capsule containing a standardized blend of cannabinoids for managing cancer anorexia-cachexia syndrome, alongside Cannabics CDx, an ex-vivo drug sensitivity diagnostic tool. Incorporated in 2004, the company, based in Bethesda, Maryland, was formerly known as Cannabics Pharmaceuticals Inc. before officially changing its name in March 2022. It operates as a subsidiary of Cannabics Inc.
Show more...
CEO
Mr. Gabriel Yariv
Employees
1
Country
United States
ISIN
US13764M2098
Listings
0 Comments
Share your thoughts
FAQ
What is CNBX Pharmaceuticals stock price today?▼
The current price of CNBX is $0.00 USD — it has increased by +29.03% in the past 24 hours. Watch CNBX Pharmaceuticals stock price performance more closely on the chart.
What is CNBX Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange CNBX Pharmaceuticals stocks are traded under the ticker CNBX.
Is CNBX Pharmaceuticals stock price growing?▼
CNBX stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year CNBX Pharmaceuticals has showed a -80% decrease.
What is CNBX Pharmaceuticals market cap?▼
Today CNBX Pharmaceuticals has the market capitalization of 174,153.6
What were CNBX Pharmaceuticals earnings last quarter?▼
CNBX earnings for the last quarter are -0.01 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is CNBX Pharmaceuticals revenue for the last year?▼
CNBX Pharmaceuticals revenue for the last year amounts to 0 USD.
What is CNBX Pharmaceuticals net income for the last year?▼
CNBX net income for the last year is -628,000 USD.
How many employees does CNBX Pharmaceuticals have?▼
As of June 10, 2026, the company has 1 employees.
In which sector is CNBX Pharmaceuticals located?▼
CNBX Pharmaceuticals operates in the Health & Wellness sector.
When did CNBX Pharmaceuticals complete a stock split?▼
The last stock split for CNBX Pharmaceuticals was on May 12, 2022 with a ratio of 1:120.
Where is CNBX Pharmaceuticals headquartered?▼
CNBX Pharmaceuticals is headquartered in Bethesda, United States.